PerkinElmer to Pay Dividend May 28, 2008 Save for later NEW YORK (GenomeWeb News) – PerkinElmer said today that its board of directors has declared a quarterly dividend of $.07 per common share. The dividend is payable on Aug. 8 to shareholders of record at the close of business on July 18. Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans. What's Popular? All of Us Researchers Make Case for Long Reads in Population Sequencing Premium People in the News at Illumina, Centogene, BioSkryb NanoString Technologies, Weill Cornell Medicine Collaborate on Spatial Atlas of Human Tissues Bionano Genomics Obtains China NMPA Approval for DNA Extraction, Labeling Products Premium Twist Bioscience Shares Fall 17 Percent as Fiscal Q2 Guidance Comes In Below Wall Street Estimates
